CAM
UTHR icon

Cozad Asset Management’s United Therapeutics UTHR Stock Holding History

Cozad Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
2,960
-20
-0.7% -$11.3K 0.1% 186
2026
Q1 		$1.77M Buy
2,980
+10
+0.3% +$4.98K 0.14% 160
2025
Q4 		$1.45M Sell
2,970
-20
-0.7% -$9.31K 0.11% 179
2025
Q3 		$1.25M Buy
2,990
+346
+13% +$116K 0.1% 189
2025
Q2 		$760K Buy
2,644
+839
+46% +$251K 0.07% 233
2025
Q1 		$556K Buy
+1,805
New +$619K 0.06% 255

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cozad Asset Management's UTHR Position: Q2 2026 in Review

Cozad Asset Management reduced its United Therapeutics (UTHR) stake by 0.67% in Q2 2026, selling an estimated $11.3K and leaving 2,960 shares worth $1.6M. The position accounts for 0.1% of the portfolio, ranked #186.

Cozad Asset Management first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.77M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cozad Asset Management held 2,960 shares of United Therapeutics worth $1.6M as of Q2 2026.
  • Cozad Asset Management sold 20 United Therapeutics shares in Q2 2026, an estimated $11.3K.
  • United Therapeutics made up 0.1% of Cozad Asset Management's portfolio in Q2 2026, its #186 holding.
  • Cozad Asset Management first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Cozad Asset Management's United Therapeutics position peaked at $1.77M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.